These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2425935)

  • 21. Myeloperoxidase oxidizes mitoxantrone to metabolites which bind covalently to DNA and RNA.
    Panousis C; Kettle AJ; Phillips DR
    Anticancer Drug Des; 1995 Dec; 10(8):593-605. PubMed ID: 8595120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective binding of elliptinium acetate onto the 3'-terminal ribose of diribonucleosides monophosphates.
    Pratviel G; Bernadou J; Paoletti C; Meunier B; Gillet B; Guittet E; Lallemand JY
    Biochem Biophys Res Commun; 1985 May; 128(3):1173-9. PubMed ID: 2408615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of the glucuronide and glutathione conjugates of the antitumor drug N2-methyl-9-hydroxyellipticinium acetate (Celiptium). Comparative disposition of this drug with its olivacinium isomer in rat bile.
    Maftouh M; Monsarrat B; Rao RC; Meunier B; Paoletti C
    Drug Metab Dispos; 1984; 12(1):111-9. PubMed ID: 6141901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione.
    Geroni C; Marchini S; Cozzi P; Galliera E; Ragg E; Colombo T; Battaglia R; Howard M; D'Incalci M; Broggini M
    Cancer Res; 2002 Apr; 62(8):2332-6. PubMed ID: 11956092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of deuterium-labelled elliptinium and its use in metabolic studies.
    Gouyette A
    Biomed Environ Mass Spectrom; 1988 Mar; 15(5):243-7. PubMed ID: 3365494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor activity of cytidine dialdehyde and its effects on nucleotide and nucleic acid synthesis.
    Kinahan JJ; Pavelic ZP; Leonard RJ; Bloch A; Grindey GB
    Cancer Res; 1980 Mar; 40(3):598-603. PubMed ID: 7471080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CC-1065 (NSC 298223), a novel antitumor agent that interacts strongly with double-stranded DNA.
    Li LH; Swenson DH; Schpok SL; Kuentzel SL; Dayton BD; Krueger WC
    Cancer Res; 1982 Mar; 42(3):999-1004. PubMed ID: 6174220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reductive metabolism of niridazole by adult Schistosoma mansoni. Correlation with covalent drug binding to parasite macromolecules.
    Tracy JW; Catto BA; Webster LT
    Mol Pharmacol; 1983 Sep; 24(2):291-9. PubMed ID: 6193406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. omicron-Quinone formation in the biochemical oxidation of the antitumor drug N2-methyl-9-hydroxyellipticinium acetate.
    Bernadou J; Meunier G; Paoletti C; Meunier B
    J Med Chem; 1983 Apr; 26(4):574-9. PubMed ID: 6834391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proposed mechanism of therapeutic selectivity for 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia based upon lower capacities for transport and phosphorylation in proliferative intestinal epithelium compared to tumor cells.
    Barrueco JR; Jacobsen DM; Chang CH; Brockman RW; Sirotnak FM
    Cancer Res; 1987 Feb; 47(3):700-6. PubMed ID: 3802076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of N-hydroxy-N'-aminoguanidine derivatives on ribonucleotide reductase activity, nucleic acid synthesis, clonogenicity, and cell cycle of L1210 cells.
    Weckbecker G; Weckbecker A; Lien EJ; Cory JG
    Cancer Res; 1987 Feb; 47(4):975-8. PubMed ID: 2433036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
    Auclair C; Paoletti C
    J Med Chem; 1981 Mar; 24(3):289-95. PubMed ID: 7265115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor activity of 9-hydroxyellipticine (NSC 210717) ON L1210 mouse leukemia and the effect of route of injection.
    Le Pecq JB; Gosse C; Nguyen-Dat-Xuong ; Cros S; Paoletti C
    Cancer Res; 1976 Sep; 36(9 pt.1):3067-76. PubMed ID: 975074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor activity and nucleic acid binding properties of dercitin, a new acridine alkaloid isolated from a marine Dercitus species sponge.
    Burres NS; Sazesh S; Gunawardana GP; Clement JJ
    Cancer Res; 1989 Oct; 49(19):5267-74. PubMed ID: 2548717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cytotoxic action of 1,3,5-triazabicyclo[3.1.0]hexane-2,4-diones and 1,3,5-triazine-4,6-(1 H,5 H)-diones in murine and human tumor cells.
    Hall IH; Taylor K; Izydore RA; Coleman DE; Mitchell JA; Cummings R
    Pharmazie; 1998 Jun; 53(6):398-405. PubMed ID: 9675770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of L1210 cell growth inhibition by the bacterial iron chelators parabactin and compound II.
    Cavanaugh PF; Porter CW; Tukalo D; Frankfurt OS; Pavelic ZP; Bergeron RJ
    Cancer Res; 1985 Oct; 45(10):4754-9. PubMed ID: 4027962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for electrophilic properties of N2-methyl-9-hydroxy ellipticinium acetate (Celiptium) from human biliary metabolites.
    Bernadou J; Monsarrat B; Roche H; Armand JP; Paoletti C; Meunier B
    Cancer Chemother Pharmacol; 1985; 15(1):63-5. PubMed ID: 4006051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physicochemical and pharmacological properties of the antitumor ellipticine derivative 2-(diethylamino-2-ethyl)9-hydroxy ellipticinium-chloride, HCl.
    Auclair C; Pierre A; Voisin E; Pepin O; Cros S; Colas C; Saucier JM; Verschuere B; Gros P; Paoletti C
    Cancer Res; 1987 Dec; 47(23):6254-61. PubMed ID: 3677074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of protein-associated DNA breaks by 10-[diethylaminopropylamino]-6-methyl-5H-pyrido[3',4':4,5]pyrrolo [2,3-g]isoquinoline in cultured L1210 cells and in isolated nuclei: comparison with other topoisomerase II inhibitors.
    Pierson V; Pierre A; Pommier Y; Gros P
    Cancer Res; 1988 Mar; 48(6):1404-9. PubMed ID: 2830964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of macromolecular biosynthesis in cultured L1210 mouse leukemia cells by thalicarpine (NSC 68075).
    Allen LM; Creaven PJ
    Cancer Res; 1973 Dec; 33(12):3112-6. PubMed ID: 4796799
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.